Back
Brainstorm Cell Therapeutics Vs. Arch Resources Industry Stock Comparison
Sell
37
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.36
Seasonality Move:
15.02%
Buy
76
ARCH
Arch Resources
Last Price:
163.97
Seasonality Move:
22.26%
Sell
37
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.37. The Score for BCLI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Arch Resources (ARCH)
is a Buy
Is Arch Resources a Buy, Sell or Hold?
- The current Arch Resources [ARCH] share price is $164.20. The Score for ARCH is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- ARCH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARCH Stock Price Chart
What is Arch Resources's stock price today?
-
The Arch Resources share price today is $164.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCH is experiencing slight selling pressure.
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.35 | Sell |
| Chaikin Money Flow: | 324820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.46) | Sell |
| Bollinger Bands (100): | (0.35 - 0.57) | Sell |
ARCH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 54.37 | Buy |
| Chaikin Money Flow: | -39422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (152.34 - 169.36) | Buy |
| Bollinger Bands (100): | (155.79 - 170.87) | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Buy |
| 20-day SMA: | 0.4 | Sell |
| 50-day SMA: | 0.45 | Sell |
| 200-day SMA: | 0.37 | Sell |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.4 | Sell |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 0.65 | Sell |
ARCH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 158.25 | Buy |
| 20-day SMA: | 158.25 | Buy |
| 50-day SMA: | 161.92 | Buy |
| 200-day SMA: | 162.9 | Buy |
| 8-day EMA: | 161.11 | Buy |
| 20-day EMA: | 159.84 | Buy |
| 50-day EMA: | 161.28 | Buy |
| 200-day EMA: | 158.77 | Buy |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.
Arch Resources Earnings Growth & ARCH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.24 per share, an increase next quarter of $1.09 per share, a decrease this year of $10.11 per share, and an increase next year of $8.16 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arch Resources Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||